Targeting Hypertension with the Peregrine System™ Infusion Catheter using Dehydrated Alcohol Injection, USP
Ablative Solutions is studying the use of the 510(K) Cleared Peregrine System™ Infusion Catheter with Dehydrated Alcohol Injection, USP in a transcatheter alcohol-mediated renal denervation procedure with the goal of helping reduce blood pressure for people with hypertension that is not well controlled.
Hypertension
Peregrine System Infusion Catheter
The alcohol-mediated renal denervation procedure is performed using the Peregrine Catheter, which is designed to deliver a neurolytic solution (Dehydrated Alcohol Injection, USP) in the perivascular space of the renal artery to ablate the nerves known to influence the body’s regulation of blood pressure.
Clinical Trial Program
The ASI Clinical Trial program is investigating Dehydrated Alcohol Injection, USP injected using the Peregrine Catheter to assess the efficacy and safety of this alcohol-mediated renal denervation procedure to treat uncontrolled hypertension.